Sample Size Estimation for Alzheimer’s Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging

Background: Little is known about the sample sizes required for clinical trials of Alzheimer’s disease (AD)-modifying treatments using atrophy measures from serial brain magnetic resonance imaging (MRI) in the Japanese population. Objective: The primary objective of the present study was to estimate...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujishima, Motonobu, Kawaguchi, Atsushi, Maikusa, Norihide, Kuwano, Ryozo, Iwatsubo, Takeshi, Matsuda, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240548/
https://www.ncbi.nlm.nih.gov/pubmed/27911297
http://dx.doi.org/10.3233/JAD-160621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240548/
https://www.ncbi.nlm.nih.gov/pubmed/27911297
http://dx.doi.org/10.3233/JAD-160621

Ejemplares similares